published 03/21/13
PDF
published 05/02/13
Video
This website is available in:
SGS Website
To change websites, find a country in the A - Z list then choose a language.
To change websites, click on the map pins to find a country then choose a language.
Categories
HomeLife SciencesClinical Research ServicesEarly Phase I-IIaBioanalytical ServicesPharmacokinetic Testing
In order to support the bioanalysis of various classes of compounds (including peptides), SGS offers a large range of techniques and methods providing rapid high volume bioanalysis. Our method development processes focus on high-throughput technological capabilities (e.g. TurboFlow extraction, multiprobe robots).
SGS offers more than 700 validated bioanalysis methods that are ready for use with a very short lead-time. Validation criteria follow guidelines from the FDA (May 2001) and the Crystal City Conference (May 2006). All validations are tailored to specific program requirements.
Dry Blood Spot (DBS) technology has several advantages for toxicokinetic (TK) and pharmacokinetic (PK) analysis, including: reduced blood sampling collection, absence of post-collection processing, low biohazard risk, fewer required facilities for sample shipment and storage. Furthermore, sample analysis can also be simplified.
To support the bioanalysis of various classes of compounds, a large range of techniques and methods are available to you. Also, an exceptional sample processing and analytical capabilities, combined with scientific expertise, enables us to provide rapid, high-volume bioanalysis:
published 02/28/12
published 02/29/12
published 06/06/12
May19
May21